Kezar Life Sciences, Inc. — All Filings
447 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
3
3/A
4
424B4
424B5
5
8-A12B
8-A12B/A
8-K
ARS
CERT
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
POSASR
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | — | 0001415889-25-001368 | Jan 13, 2025 | Jan 9, 2025 |
| 4 | — | 0001415889-25-001366 | Jan 13, 2025 | Jan 9, 2025 |
| 8-K | 8-K | 0001645666-25-000001 | Jan 10, 2025 | — |
| 8-K | 8-K | 0000950170-24-132818 | Dec 3, 2024 | — |
| 8-K | 8-K | 0000950170-24-127038 | Nov 14, 2024 | Nov 13, 2024 |
| 10-Q | 10-Q | 0000950170-24-125457 | Nov 12, 2024 | Sep 30, 2024 |
| 8-K | 8-K | 0000950170-24-125351 | Nov 12, 2024 | — |
| 8-A12B/A | 8-A12B/A | 0000950170-24-118343 | Oct 29, 2024 | — |
| 8-K | 8-K | 0000950170-24-117723 | Oct 28, 2024 | — |
| 8-K | 8-K | 0001193125-24-238562 | Oct 17, 2024 | — |
| 8-A12B | 8-A12B | 0001193125-24-238576 | Oct 17, 2024 | — |
| 8-K | 8-K | 0000950170-24-113963 | Oct 10, 2024 | — |
| SC 13D | — | 0001214659-24-017295 | Oct 8, 2024 | — |
| 8-K | 8-K | 0000950170-24-112969 | Oct 4, 2024 | — |
| 8-K | 8-K | 0000950170-24-110177 | Sep 30, 2024 | — |
| 8-K | 8-K | 0000950170-24-096165 | Aug 13, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-096213 | Aug 13, 2024 | Jun 30, 2024 |
| 4 | — | 0001415889-24-020202 | Jul 26, 2024 | Jul 2, 2024 |
| SC 13G/A | — | 0001086364-24-008149 | Jul 8, 2024 | — |
| 4 | — | 0001415889-24-017837 | Jun 21, 2024 | Jun 20, 2024 |
| 8-K | 8-K | 0000950170-24-076234 | Jun 21, 2024 | Jun 18, 2024 |
| 4 | — | 0001415889-24-017838 | Jun 21, 2024 | Jun 20, 2024 |
| 4 | — | 0001415889-24-017839 | Jun 21, 2024 | Jun 20, 2024 |
| 4 | — | 0001415889-24-017840 | Jun 21, 2024 | Jun 20, 2024 |
| 4 | — | 0001415889-24-017841 | Jun 21, 2024 | Jun 20, 2024 |
| 4 | — | 0001415889-24-017836 | Jun 21, 2024 | Jun 20, 2024 |
| 8-K | 8-K | 0000950170-24-068730 | Jun 4, 2024 | May 31, 2024 |
| 8-K | 8-K | 0000950170-24-056871 | May 9, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-056918 | May 9, 2024 | Mar 31, 2024 |
| ARS | ARS | 0000950170-24-049133 | Apr 26, 2024 | Dec 31, 2023 |
| DEF 14A | DEF 14A | 0000950170-24-049099 | Apr 26, 2024 | — |
| DEFA14A | DEFA14A | 0000950170-24-049121 | Apr 26, 2024 | — |
| PRE 14A | PRE 14A | 0000950170-24-044789 | Apr 16, 2024 | — |
| 424B5 | 424B5 | 0001193125-24-075201 | Mar 22, 2024 | — |
| 10-K | 10-K | 0000950170-24-031494 | Mar 14, 2024 | Dec 31, 2023 |
| S-8 | S-8 | 0000950170-24-031541 | Mar 14, 2024 | — |
| 8-K | 8-K | 0000950170-24-031448 | Mar 14, 2024 | — |
| SC 13G/A | AMENDMENT NO. 1 | 0000947871-24-000153 | Feb 14, 2024 | — |
| SC 13G/A | — | 0000919574-24-001238 | Feb 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001193125-24-033054 | Feb 13, 2024 | — |
| SC 13G/A | — | 0000919574-24-000940 | Feb 13, 2024 | — |
| SC 13G/A | — | 0001086364-24-005081 | Jan 29, 2024 | — |
| SC 13G/A | — | 0001273087-24-000021 | Jan 22, 2024 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-24-001777 | Jan 17, 2024 | Jan 15, 2024 |
| 4 | FORM 4 SUBMISSION | 0001209191-24-001254 | Jan 9, 2024 | Jan 7, 2024 |
| 4 | FORM 4 SUBMISSION | 0001209191-24-001253 | Jan 9, 2024 | Jan 7, 2024 |
| 8-K | 8-K | 0000950170-24-002728 | Jan 8, 2024 | — |
| 8-K | 8-K | 0000950170-23-067777 | Dec 4, 2023 | Dec 1, 2023 |
| 10-Q | 10-Q | 0000950170-23-062950 | Nov 13, 2023 | Sep 30, 2023 |
| 8-K | 8-K | 0000950170-23-062918 | Nov 13, 2023 | — |